申请人:MITSUYA MORIHIRO
公开号:US20100041660A1
公开(公告)日:2010-02-18
The present invention relates to a compound which has a glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus, being represented by a formula (I):
[wherein X
1
represents a nitrogen atom, sulfur atom, oxygen atom or the like; R
1
represents a 6- to 10-membered aryl group, 5- to 7-membered heteroaryl group or the like; D represents an oxygen atom or sulfur atom; R
2
and R
3
are the same or different, each representing a hydrogen atom, lower alkyl group or the like; a formula (II)
represents an optionally substituted 5- to 7-membered heteroaryl group or the like; a formula (III)
represents a monocyclic or bicyclic heteroaryl group] or a pharmaceutically acceptable salt thereof.
本发明涉及一种具有葡萄糖激酶激活作用并且可用作糖尿病治疗剂的化合物,其化学式为(I):[其中X1代表氮原子、硫原子、氧原子或类似物;R1代表6到10个成员的芳基基团、5到7个成员的杂芳基团或类似物;D代表氧原子或硫原子;R2和R3相同或不同,每个代表氢原子、低碳基团或类似物;化学式(II)代表可选取代的5到7个成员的杂芳基团或类似物;化学式(III)代表单环或双环杂芳基团]或其药学上可接受的盐。